News

Exciting Financing Moves for Indoor Waterpark and Hotel

Exciting Financing Moves for Indoor Waterpark and Hotel

BGL Real Estate Advisors Secures $135 Million Financing

Brown Gibbons Lang & Company (BGL), a premier independent investment firm, has achieved a significant milestone by structuring $135 million in real estate financing aimed at advancing the construction of an indoor waterpark and a new hotel at Hall of Fame Village. This financing opportunity is set to enhance the visitor experience in the area, bringing exciting developments right next to the Pro Football Hall of Fame.

Significance of the Financing

The financing package involves $70 million sourced from Commercial Property Assessed Clean Energy (C-PACE) initiatives, marking it as the largest C-PACE loan for a single project in Ohio. This capital support is crucial for the ongoing development of an 85,000 square foot indoor waterpark and initiating the construction of a 183-key hotel, aimed at attracting tourists and enhancing local business opportunities.

Expert Insights on C-PACE Financing

Jared Schlosser, Head of Credit Originations and C-PACE at Peachtree, emphasized the effectiveness of C-PACE as a financing tool in today’s real estate market. He mentioned that it plays a pivotal role in addressing immediate capital needs while providing long-term financial stability. These advantages make it a vital resource for building owners looking to bolster their investment without straining existing financial resources.

Previous Funding Transactions

BGL previously established a $33.4 million C-PACE financing for the Tom Benson Hall of Fame Stadium in 2022. Together with the current funding, Peachtree’s total investment for the Hall of Fame Village now reaches approximately $103.4 million. This cumulative funding demonstrates a solid commitment to the growth and development of Hall of Fame Village, ensuring that infrastructure aligns with the goals of the surrounding community.

Transition to Private Ownership and Future Prospects

The Hall of Fame Resort & Entertainment Company, which oversees Hall of Fame Village, transitioned from a publicly traded entity to a private company earlier this year following a merger with HOFV Holdings. This transition is expected to invigorate investment opportunities within Hall of Fame Village, helping the company focus on sustainable development and long-term value for stakeholders.

BGL's Real Estate Advisors Group Commitment

BGL's Real Estate Advisors group provides specialized services tailored for middle-market real estate transactions, including advisory and capital placement services. The team is dedicated to helping real estate owners and developers within a broad array of asset classes, facilitating partnerships and joint ventures that meet diverse capital needs.

About Brown Gibbons Lang & Company

Brown Gibbons Lang & Company is a renowned investment banking and financial advisory firm concentrating on the global middle market. With operations in major U.S. cities including Chicago, Cleveland, and New York, BGL advises entities on mergers and acquisitions, capital markets strategies, and more. The firm's expert team is committed to providing its clients with innovative and effective insights across the financial landscape.

About Hall of Fame Village

Hall of Fame Resort & Entertainment Company is focused on developing a multifaceted sports and entertainment environment centered around the Pro Football Hall of Fame. The ongoing initiatives aim to attract a diverse range of visitors while supporting local economic growth and community engagement.

Frequently Asked Questions

What is the purpose of the $135 million financing?

The financing aims to support the development of a new indoor waterpark and a hotel at Hall of Fame Village.

Who provided the C-PACE financing?

The Peachtree Group was instrumental in providing the C-PACE financing for the project.

What is C-PACE?

C-PACE stands for Commercial Property Assessed Clean Energy, which is a financing mechanism that helps property owners fund energy and water efficiency upgrades.

How does this financing benefit the local community?

This financing will boost local tourism, create jobs, and stimulate economic growth around Hall of Fame Village.

What are BGL's services?

BGL provides a range of real estate investment banking services, focusing on advisory, capital placement, and financial strategies for the middle market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

FIRSTHABIT Celebrates Inspiring Winners of CHALK AI Math Challenge

Updated Category News Views 103

FIRSTHABIT Concludes the CHALK AI Math Challenge with Enthusiastic Participation At the recent CES 2026, a global technology showcase, FIRSTHABIT marked a remarkable achievement by successfully conducting the CHALK AI Math Challenge, drawing in participants eager to engage with innovative learning tools. This event, held in a vibrant setting at Eureka Park within the...

Continue Reading
Tesla Class Action Lawsuit: Investors Alert and Legal Options

Updated Category News Views 128

Understanding the Tesla Class Action Lawsuit Tesla, Inc. has come under scrutiny with a recent class action lawsuit that could impact many investors. This case primarily involves individuals who purchased Tesla securities during the specified class period. Investors are seeking to recover their losses related to misleading statements made by the company regarding its...

Continue Reading
DNA Nanobots Welcomes Dr. John C. Byrd to Advisory Board

Updated Category News Views 167

Innovative Leadership at DNA Nanobots DNA Nanobots, a pioneering biotechnology firm centered on the development of DNA nanoparticles for targeted therapeutic solutions, is thrilled to announce the addition of Dr. John C. Byrd, M.D. to its Scientific Advisory Board (SAB). Known for his substantial contributions to the field of blood cell cancer therapies, Dr. Byrd's...

Continue Reading
Stock Market Insights: Growth Trends and Economic Indicators

Updated Category News Views 140

Market Reactions to Political Events Recently, there has been significant activity in the stock market following political announcements. A recent framework discussion regarding Greenland led to a surprising impact on stocks. This event sparked an immediate relief rally in which major indexes ended the day up by over 1%. The Russell 2000 index, a benchmark for small-cap...

Continue Reading
ARTHEx Biotech Secures $87 Million to Propel RNA Medicines Forward

Updated Category News Views 315

ARTHEx Biotech Secures $87 Million to Propel RNA Medicines Forward ARTHEx Biotech S.L., a cutting-edge biotechnology company that is at the forefront of developing targeted RNA medicines, has achieved a significant milestone by successfully closing its upsized Series B financing. This funding round, which now totals $87 million, was primarily led by Bpifrance, a new...

Continue Reading